patent cliff
PMLiVE’s Top Pharma list is live
The data was provided by GlobalData, a data analysis and consulting company
Full impact of COVID-19 pandemic on cancer treatment unknown, according to GlobalData
World Cancer Day (4 February 2021) is aiming to address systemic weaknesses exacerbated by pandemic
Immuno-oncology, personalised medicine continues to drive pharma sector
New GlobalData survey identifies key trends impacting the industry
Personalised medicine can improve treatment, but access still an issue
Barriers to access could harm uptake of potentially transformative therapies
Top three therapeutic areas lead pharma’s pipeline
Oncology dominates followed by CNS disorders and infectious diseases
Otsuka joins forces with IBM for Watson-based digital venture
Otsuka Digital Health will develop software to analyse psychiatric patient data
2015 set to be a transitional year for Merck KGaA’s health unit
Weak pharma sales reported by the firm today
Teva starts M&A push with $3.5bn Auspex buy
Aims to diversify business away from dependency on Copaxone
Neurodegenerative research needs better cooperation, say GlobalData
And public funding must be provided to eradicate business risks
Type 1 diabetes market to double to $13.6bn
New treatments will see this growth by 2023, according to GlobalData
US pharma market to reach $550bn by 2020
Health reforms and the new FDA initiatives among the factors that will help it grow